INNOVIVA, INC. Proceeds from Sale and Collection of Notes Receivable
INNOVIVA, INC. (INVA) reported Proceeds from Sale and Collection of Notes Receivable of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable · last filed 2017-02-28
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for the quarter ending 2015-12-31 was $0.00.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for the quarter ending 2015-09-30 was $0.00.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for the quarter ending 2014-12-31 was $0.00.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for the quarter ending 2014-09-30 was $0.00.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for fiscal 2016 was $0.00.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for fiscal 2014 was $140.00K, a 40.00% increase from fiscal 2013.
- INNOVIVA, INC. proceeds from sale and collection of notes receivable for fiscal 2013 was $100.00K, a 58.33% decline from fiscal 2012.
| Period end | Proceeds from Sale and Collection of Notes Receivable 3 month | Proceeds from Sale and Collection of Notes Receivable 6 month | Proceeds from Sale and Collection of Notes Receivable 9 month | Proceeds from Sale and Collection of Notes Receivable 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 10-K · filed 2017-02-28 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $140.00K derived: sum of 3 quarters · filed 2017-02-28 | $140.00K 10-K · filed 2017-02-28 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $140.00K derived: sum of 2 quarters · filed 2015-11-05 | $140.00K 10-Q · filed 2015-11-05 | $140.00K derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $140.00K 10-Q · filed 2015-08-06 | $140.00K derived: sum of 3 quarters · filed 2016-02-24 | $140.00K derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $0.00 derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $100.00K 10-K · filed 2016-02-24 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $100.00K 10-Q · filed 2014-11-04 | $100.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $100.00K 10-Q · filed 2014-08-07 | $100.00K derived: sum of 3 quarters · filed 2015-02-27 | |
| 2013-03-31 | $100.00K 10-Q · filed 2014-05-07 | $100.00K derived: sum of 2 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $240.00K 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $240.00K 10-Q · filed 2013-11-01 | |||
| 2011-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $185.00K derived: sum of 2 quarters · filed 2014-03-03 | $715.00K 10-K · filed 2014-03-03 | |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $630.00K 10-Q · filed 2012-10-31 | ||
| 2011-06-30 | $530.00K 10-Q · filed 2012-08-01 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $30.00K derived: sum of 2 quarters · filed 2013-02-26 | $140.00K 10-K · filed 2013-02-26 | |
| 2010-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $140.00K 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | $110.00K 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | $375.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |